Jamaica vs Sudan: HIV/AIDS deaths averted by antiretroviral therapy
Jamaica
1,044 deaths
in 2022
Sudan
958.82 deaths
in 2024
Jamaica rank
72nd
Sudan rank
75th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Jamaica
- Sudan
How they compare
Jamaica currently reports 1,044 deaths against 958.82 deaths in Sudan, a difference of 85.18 deaths.
That makes Jamaica's figure about 1.1 times Sudan's.
The two have swapped places 2 times across 33 shared years of data; in 1990 it was Sudan ahead.
Jamaica ranks 72nd and Sudan ranks 75th of 157 countries.
Jamaica has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Jamaica | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 310 deaths | 104.25 deaths | 205.75 deaths | Jamaica |
| 2010s | 1,136 deaths | 556.8 deaths | 579.7 deaths | Jamaica |
| 2020s | 1,127 deaths | 1,089 deaths | 37.98 deaths | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Jamaica or Sudan?
- Jamaica, at 1,044 deaths against 958.82 deaths in Sudan as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Jamaica and Sudan?
- 85.18 deaths, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and Sudan?
- 33 years are reported by both, from 1990 to 2022.
- How do Jamaica and Sudan rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Jamaica ranks 72nd and Sudan ranks 75th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.